Over the last 12 months, Neogenomics insiders reported no purchases and 3 sales totaling $440K across SEC Form 4 filings. 67% of the activity was filed under pre-arranged 10b5-1 trading plans.
| Date | Insider | Type | Shares | Avg price | Value | Δ stake | Marks |
|---|---|---|---|---|---|---|---|
| Aug 4, 2026 | Aunan Greg DChief Accounting Officer · O | ▼ Sale | 20,000 | $16.07 | $321K | -79.5% | — |
| Jun 15, 2026 | TETRAULT LYNN A.D | ▼ Sale | 5,307 | $11.1 | $59K | -5.8% | plan |
| Jun 9, 2026 | TETRAULT LYNN A.D | ▼ Sale | 5,307 | $11.29 | $60K | -5.5% | plan |
Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $NEO feed.